Lv1
40 积分 2025-12-10 加入
High activity, pain reduction and low toxicity with Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): results of a phase II prospective trial
2天前
求助中
Theranostic Nuclear Medicine with Gallium-68, Lutetium-177, Copper-64/67, Actinium-225, and Lead-212/203 Radionuclides
2天前
已完结
In Vivo Bioorthogonal Radiolabeling of Nanoparticles to Minimize Liver Radiation
2个月前
已完结
Spin‐State Modulation of Iron Oxide Nanoparticles via Cobalt(III) Engineering Enables Precision MRI Contrast at Ultra‐High‐Field
3个月前
已完结
High-field magnetic resonance imaging: Challenges, advantages, and opportunities for novel contrast agents
3个月前
已完结
Functional imaging: a game changer for biomarker discovery and treatment response among patients with hepatocellular carcinoma
3个月前
已完结
CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma
3个月前
已完结
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy
4个月前
已完结
皖公网安备34019202002308
